RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT)

Authors
BYINGTON RP MILLER ME HERRINGTON D RILEY W PITT B FURBERG CD HUNNINGHAKE DB MANCINI GBJ
Citation
Rp. Byington et al., RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT), The American journal of cardiology, 80(8), 1997, pp. 1087
Citations number
8
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
The American journal of cardiology → ACNP
ISSN journal
00029149
Volume
80
Issue
8
Year of publication
1997
Database
ISI
SICI code
0002-9149(1997)80:8<1087:RDABCO>2.0.ZU;2-9
Abstract
The Prospective Randomized Evaluation of the Vascular Effects of Norva sc Trial is the first angiographic clinical trial to be designed to te st whether an agent can slow or even reverse the progression of early coronary atherosclerosis in patients with documented disease, In addit ion, a subset of patients are undergoing carotid ultrasound examinatio ns, providing a unique opportunity to assess and correlate disease pro gression in 2 arterial beds.